Close
ACHEMA MIDDLE EAST 2026

FDA Clears Novavax COVID-19 Vaccine As Fourth Option In US

As infections in the U.S. continue to be at high levels, the Food and Drug Administration on 13th July approved a fourth vaccination for...

Indian Pharma Business May Increase 8-11%, Predicts Alkem

When the epidemic subsides, Alkem Laboratories predicts that inflationary pressures and shifting regulatory standards will be the primary concerns to keep an eye on,...

Lonza To Construct $518mn Fill-Finish Plant In Switzerland

Lonza, a major CDMO, is to invest $518 million in a new, massive fill-finish manufacturing facility in Stein, Switzerland. According to the firm, the...

Pfizer And Touchlight Enter Into A Patent Collaboration

Pfizer and another pharmaceutical major, Touchlight, have come to a deal on a significant non-exclusive patent licence. Touchlight is a firm that focuses on...

AstraZeneca, GSK Weathered Q2 Storm, But Roche Stock Plunged

The standard response to any poor performance is to blame the supply chain, which has almost attained the status of a joke. However, it...

Paxlovid Allowed By FDA To Sell At Certified Pharmacies

On July 6, the US Food and Drug Administration modified the COVID-19 antiviral drug Paxlovid's emergency use authorization to permit state-licensed pharmacists to recommend the...

Deloitte Believes Mature R&D Firms Reap Enterprise Value

According to the third Real-World Evidence (RWE) benchmarking survey published in June 2022 by Deloitte, there is a segmentation of outcomes between businesses with...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...